EDGAR Filing Documents for 0001213900-15-001810

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001213900-15-001810

Filing Date

2015-03-16

Accepted

2015-03-16 17:15:21

Documents

Period of Report

2015-02-18

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	f4021815dave_actinium.html	4
1	OWNERSHIP DOCUMENT	f4021815dave_actinium.xml	4	3967
	Complete submission text file	0001213900-15-001810.txt		5421

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036

Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131

Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618

Business Address

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 15703970